The role of hypoxia-inducible factor 1 in atherosclerosis

Journal of Clinical Pathology

Volumn 65, Issue 10, 2012, Pages 872-876

  Gao, Linggen ^a   Chen, Qian ^a   Zhou, Xianliang ^b   Fan, Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DENDRITIC CELL; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HYPOXIA; INFLAMMATION; LEUKOCYTE; LIPID STORAGE; MACROPHAGE; MAST CELL; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; TH1 CELL;

APOPTOSIS; ATHEROSCLEROSIS; CELL HYPOXIA; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FOAM CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LEUKOCYTES; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC;

EID: 84866940088     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200828     Document Type: Review

References (78)

1. Sluimer JC, Gasc JM, van Wanroij JL, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008;51:1258-65. (Pubitemid 351400903)
2. Hulten LM, Levin M. The role of hypoxia in atherosclerosis. Curr Opin Lipidol 2009;20:409-14.
3. Bjornheden T, Levin M, Evaldsson M, et al. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1999;19:870-6. (Pubitemid 29177331)
4. Kuwahara F, Kai H, Tokuda K, et al. Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 2002;39:46-50. (Pubitemid 34098087)
5. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32. (Pubitemid 37328811)
6. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic helixeloopehelixe PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92:5510-14.
7. Li H, Ko HP, Whitlock JP. Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha. J Biol Chem 1996;271:21262-7. (Pubitemid 26292983)
8. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997;272:22642-7. (Pubitemid 27386079)
9. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70:1469-80.
10. Tekin D, Dursun AD, Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin 2010;31:1085-94.
11. Semenza GL, Nejfelt MK, Chi SM, et al. Hypoxia-inducible nuclear factors bind to an enhancer element located 39 to the human erythropoietin gene. Proc Natl Acad Sci U S A 1991;88:5680-4. (Pubitemid 21914809)
12. Ten VS, Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002;8:242-50. (Pubitemid 34575841)
13. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:29-38. (Pubitemid 40054251)
14. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 2000;88:1880-9. (Pubitemid 30336942)
15. Pearlstein DP, Ali MH, Mungai PT, et al. Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol 2002;22:566-73. (Pubitemid 34408735)
16. Grishko V, Solomon M, Breit JF, et al. Hypoxia promotes oxidative base modifications in the pulmonary artery endothelial cell VEGF gene. FASEB J 2001;15:1267-9.
17. Pennings M, Meurs I, Ye D, et al. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 2006;580:5588-96. (Pubitemid 44465904)
18. Burke B, Tang N, Corke KP, et al. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 2002;196:204-12. (Pubitemid 34110902)
19. Griffiths L, Binley K, Iqball S, et al. The macrophage e a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 2000;7:255-62. (Pubitemid 30113775)
20. Fang HY, Hughes R, Murdoch C, et al. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009;114:844-59.
21. Oda T, Hirota K, Nishi K, et al. Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 2006;291:C104-13.
22. Ben-Shoshan J, Afek A, Maysel-Auslender S, et al. HIF-1alpha overexpression and experimental murine atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29:665-70.
23. Houtkamp MA, de Boer OJ, van der Loos CM, et al. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol 2001;193:263-9. (Pubitemid 32118139)
24. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol 2009;31:35-47.
25. Walmsley SR, Cadwallader KA, Chilvers ER. The role of HIF-1alpha in myeloid cell inflammation. Trends Immunol 2005;26:434-9. (Pubitemid 41008080)
26. Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha is essential for myeloid cellmediated inflammation. Cell 2003;112:645-57. (Pubitemid 36331777)
27. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101. (Pubitemid 24296363)
28. Kong T, Eltzschig HK, Karhausen J, et al . Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci U S A 2004;101:10440-5. (Pubitemid 38924944)
29. Millonig G, Niederegger H, Rabl W, et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 2001;21:503-8. (Pubitemid 32323380)
30. Shaposhnik Z, Wang X, Weinstein M, et al. Granulocyte macrophage colonystimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2007;27:621-7.
31. Jantsch J, Chakravortty D, Turza N, et al. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol 2008;180:4697-705.
32. Agis H, Willheim M, Sperr WR, et al. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 1993;151:4221-7. (Pubitemid 23298755)
33. Fodinger M, Fritsch G, Winkler K, et al. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994;84:2954-9. (Pubitemid 24328084)
34. Kirshenbaum AS, Goff JP, Semere T, et al. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999;94:2333-42. (Pubitemid 29467681)
35. Jeong HJ, Chung HS, Lee BR, et al. Expression of proinflammatory cytokines via HIF- 1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 2003;306:805-11.
36. Lee KS, Kim SR, Park SJ, et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am J Respir Crit Care Med 2008;178:787-97.
37. Osada-Oka M, Ikeda T, Imaoka S, et al. VEGF-enhanced proliferation under hypoxia by an autocrine mechanism in human vascular smooth muscle cells. J Atheroscler Thromb 2008;15:26-33.
38. Zhang R, Wu Y, Zhao M, et al. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2009;297:L631-640.
39. Diebold I, Djordjevic T, Hess J, et al. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb Haemost 2008;100:1021-8.
40. Schultz K, Murthy V, Tatro JB, et al . Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}- dependent mechanisms. Am J Physiol Lung Cell Mol Physiol 2009;296:L921-7.
41. Verschuren L, Kooistra T, Bernhagen J, et al. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 2009;105:99-107.
42. Schober A, Bernhagen J, Weber C. Chemokine-like functions of MIF in atherosclerosis. J Mol Med (Berl) 2008;86:761-70.
43. Schmeisser A, Marquetant R, Illmer T, et al. The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 2005;178:83-94. (Pubitemid 39600819)
44. Noels H, Bernhagen J, Weber C. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis. Trends Cardiovasc Med 2009;19:76-86.
45. Fu H, Luo F, Yang L, et al. Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway. BMC Cell Biol 2010;11:66.
46. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002; 22:1370-80.
47. Tedgui A, Mallat Z. Apoptosis as a determinant of atherothrombosis. Thromb Haemost 2001;86:420-6. (Pubitemid 32663971)
48. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57:1009-14. (Pubitemid 39331346)
49. Giatromanolaki A, Koukourakis MI, Gatter KC, et al. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis. J Clin Pathol 2008;61:217-20. (Pubitemid 351218884)
50. Chai CY, Chen WT, Hung WC, et al. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 2008;61:658-64.
51. Celletti FL, Waugh JM, Amabile PG, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001;7:425-9. (Pubitemid 32298544)
52. Ihling C, Szombathy T, Bohrmann B, et al. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001;104:864-9. (Pubitemid 32778034)
53. Pasterkamp G, Schoneveld AH, Hijnen DJ, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000;150:245-53. (Pubitemid 30336536)
54. Jiang G, Li T, Qiu Y, et al. RNA interference for HIF-1alpha inhibits foam cells formation in vitro. Eur J Pharmacol 2007;562:183-90. (Pubitemid 46560502)
55. Paul SA, Simons JW, Mabjeesh NJ. HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 2004;200:20-30. (Pubitemid 38720618)
56. Tang N, Wang L, Esko J, et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004;6:485-95. (Pubitemid 39469984)
57. Khurana R, Moons L, Shafi S, et al. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 2005;111:2828-36. (Pubitemid 40791556)
58. Oikawa M, Abe M, Kurosawa H, et al. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 2001;289:39-43. (Pubitemid 33108788)
59. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002;64:993-8. (Pubitemid 35232274)
60. Oda N, Abe M, Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 1999; 178:121-32. (Pubitemid 29034855)
61. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503. (Pubitemid 24379627)
62. Kavurma MM, Bobryshev Y, Khachigian LM. Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1. J Biol Chem 2002;277:36244-52.
63. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-8. (Pubitemid 40923403)
64. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7. (Pubitemid 30430551)
65. Rodriguez G, Mago N, Rosa F. [Role of inflammation in atherogenesis]. Invest Clin 2009;50:109-29.
66. Sumbayev VV, Yasinska I, Oniku AE, et al. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PLoS One 2012;7:e34259.
67. White JR, Harris RA, Lee SR, et al. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 2004;83:1-8. (Pubitemid 37518254)
68. Imtiyaz HZ, Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 2010;345:105-20.
69. Vink A, Schoneveld AH, Lamers D, et al. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 2007;195:e69-75. (Pubitemid 350087978)
70. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008;453:807-11. (Pubitemid 351793778)
71. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factorkappaB in hypoxic inflammation. J Physiol 2008;586:4055-9.
72. Oliver KM, Taylor CT, Cummins EP. Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases. Arthritis Res Ther 2009;11:215.
73. Fukuda R, Zhang H, Kim JW, et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007;129:111-22. (Pubitemid 46507584)
74. Rapisarda A, Uranchimeg B, Scudiero DA, et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 2002;62:4316-24. (Pubitemid 34827288)
75. Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002;105:415-18. (Pubitemid 34141695)
76. Dichtl W, Dulak J, Frick M, et al . HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:58-63. (Pubitemid 36091626)
77. Loboda A, Stachurska A, Dorosz J, et al. HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation. Vascul Pharmacol 2009;51:133-9.
78. Hisada T, Ayaori M, Ohrui N, et al. Statin inhibits hypoxia-induced Endothelin-1 via accelerated degradation of HIF-1alpha in vascular smooth muscle cells. Cardiovasc Res. Published Online First: 14 April 2012. doi:10.1093/cvr/cvs110